Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Within the GLP-1RA group, discontinuing treatment for even 0.5 years was associated with a higher MACE risk compared to continued use
Tirzepatide sits slightly higher at 2 to 3% based on SURPASS trial program data
Biomed Pharmacother 120:109541 Abbas M, Ali M (2021) Protective effects of beetroot on streptozotocin-induced diabetes in adult male albino rats
Prescription GLP-1 receptor agonists produce sustained, supraphysiologic levels of GLP-1 activityfar exceeding what dietary modifications can achieve
These signals are not yet the same as definitive proof of prevention, but they are promising enough to merit discussion with your clinician if youre already a candidate for these drugs for diabetes, obesity, or cardiometabolic risk
US$ 23.32
US$ 24.07
US$ 23.90
US$ 24.98
US$ 25.78
US$ 21.69
